Dipeptidase 1

From WikiMD's WELLNESSPEDIA

Dipeptidase 1 (DPEP1) is an enzyme that in humans is encoded by the DPEP1 gene located on chromosome 16. Dipeptidase 1 is a crucial enzyme involved in the metabolism of proteins, specifically in the hydrolysis of dipeptides into their constituent amino acids. This process is essential for the digestion of dietary proteins and the recycling of protein-derived molecules within cells.

Function[edit]

Dipeptidase 1 is a membrane-bound glycoprotein that is predominantly expressed in the kidney, intestine, and liver. It plays a vital role in the final steps of protein digestion and amino acid processing. By breaking down dipeptides, DPEP1 aids in the absorption of amino acids, which are critical building blocks for the synthesis of new proteins in the body. Additionally, DPEP1 is involved in the detoxification processes, as it helps in metabolizing and eliminating potentially harmful peptides derived from both endogenous and exogenous sources.

Clinical Significance[edit]

Alterations in the activity or expression of DPEP1 have been associated with various diseases and conditions. For instance, reduced activity of DPEP1 has been observed in certain renal diseases, suggesting its potential role in kidney function and health. Moreover, studies have indicated that DPEP1 may have implications in the pathophysiology of hypertension, cancer, and inflammatory diseases, making it a potential target for therapeutic interventions.

Genetic Aspects[edit]

The DPEP1 gene exhibits polymorphisms that can affect the enzyme's activity and, consequently, an individual's susceptibility to certain diseases. Research into the genetic regulation of DPEP1 and its variants offers insights into personalized medicine approaches, where treatments can be tailored based on an individual's genetic makeup.

Research and Therapeutic Potential[edit]

Given its role in protein metabolism and disease associations, DPEP1 is a subject of ongoing research. Inhibitors of DPEP1 are being explored for their therapeutic potential in treating diseases related to its function. For example, targeting DPEP1 in certain cancers may disrupt tumor growth and proliferation by interfering with the metabolic pathways that tumors exploit for survival.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.